Organon& Co. (OGN) Stock Slumping in Premarket, Here’s the Reason

Organon& Co. (OGN), a science-based pharmaceutical company, has declined 13.21% in the premarket trading session and consequently is trading at $28.74 at the time of the writing. During Friday’s regular trading session, the stock gained an increase of 0.61% and closed the day at $33.12. The plunge in aftermarket could be attributed to the Kentucky […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.